Home About Us Pipeline News Investors Contacts Careers


Puma Biotechnology, Inc. Corporate Fact Sheet


NEWS

EVENTS

CONTACT


July 22, 2014 - Puma Biotechnology Announces Positive Top Line Results from Phase III PB272 Trial in Adjuvant Breast Cancer (ExteNET Trial)
Read

July 22, 2014 - Puma Biotechnology Announces Amendment to Neratinib Licensing Agreement with Pfizer
Read

June 5, 2014 - Puma Biotechnology to Present at the Goldman Sachs 35th Annual Global Healthcare Conference
Read

June 1, 2014 - Puma Biotechnology Announces Presentation of Positive PB272 Phase II Data at the 2014 ASCO Annual Meeting
Read

May 29, 2014 - Puma Biotechnology to Present at Jefferies 2014 Global Healthcare Conference
Read


  • July 22, 2014

    Puma Biotechnology Update Details

Puma Biotechnology, Inc.
10880 Wilshire Blvd., Suite 2150
Los Angeles, CA 90024
424-248-6500 Main
424-248-6501 Fax
info@pumabiotechnology.com


Puma Biotechnology 2013 Annual Report